Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p21 Promoter Methylation Is Vital for the Anticancer Activity of Withaferin A

30 Jan 2025

Abstract excerpt

Breast cancer (BC) is a widespread malignancy that affects the lives of millions of women each year, and its resulting financial and healthcare hardships cannot be overstated. These issues, in combination with side effects and obstacles associated with the current standard of care, generate considerable interest in new potential targets for treatment as well as means for BC prevention. One potential preventive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to PARP inhibition in cancer therapy
Share to Phytochemicals and Medicinal Plants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39940977
DOI: 10.3390/ijms26031210

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p21 Promoter Methylation Is Vital for the Anticancer Activity of Withaferin APMID 39940977Read ↗

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin ASemantic proximity Read ↗

Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cellsSemantic proximity Read ↗

A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer CellsSemantic proximity Read ↗

RNA‐seq reveals novel cancer‐selective and disease subtype‐independent mechanistic targets of withaferin A in human breast cancer cellsSemantic proximity Read ↗

THOR is a targetable epigenetic biomarker with clinical implications in breast cancerSemantic proximity Read ↗

Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheresSemantic proximity Read ↗

Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53.Semantic proximity Read ↗

Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cellsSemantic proximity Read ↗

Locus-Specific DNA Methylation Editing in Mammalian Cells using a CRISPR-Based SystemSemantic proximity Read ↗

Hyperactivation of p53 using CRISPRa kills human papillomavirus driven cervical cancer cellsSemantic proximity Read ↗

Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpressionSemantic proximity Read ↗

Acetyl-11-keto-β-boswellic Acid Inhibits Precancerous Breast Lesion MCF-10AT Cells via Regulation of LINC00707/miR-206 that Reduces Estrogen Receptor-αSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.